Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Citadel Advisors LLC | 2,084,267 7.800% |
-8,221 (-0.39%) |
Filing History |
| 2024-02-14 4:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Omega Fund VI, L.P. | 2,157,623 8.100% |
2,157,623 (New Position) |
Filing History |
| 2024-02-14 4:34 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Lundbeckfond Invest A/S | 1,835,959 6.900% |
1,835,959 (New Position) |
Filing History |
| 2024-02-14 1:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
2,330,738 8.700% |
2,330,738 (New Position) |
Filing History |
| 2024-02-14 06:04 am Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
D1 Capital Partners L.P. | 2,506,607 9.400% |
2,506,607 (New Position) |
Filing History |
| 2024-02-13 4:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Longitude Capital Partners IV LLC | 2,567,100 9.600% |
2,567,100 (New Position) |
Filing History |
| 2023-12-15 4:51 pm Purchase |
2023-12-11 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Novo Holdings A/S | 1,307,829 4.900% |
13,776 (+1.06%) |
Filing History |
| 2023-12-11 5:13 pm Purchase |
2023-11-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Eventide Asset Management, LLC | 3,002,831 11.930% |
3,002,831 (New Position) |
Filing History |
| 2023-11-24 4:33 pm Purchase |
2023-11-15 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Novo Holdings A/S | 1,294,053 5.100% |
1,294,053 (New Position) |
Filing History |
| 2023-11-17 4:23 pm Purchase |
2023-11-07 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Citadel Advisors LLC | 2,092,488 8.300% |
2,092,488 (New Position) |
Filing History |